The investment seeks significant capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KIQQ | 25.13 | 0.19 | +0.75% |
| KraneSharesInspereXNasdaqDynBfrdHInIdETF | |||
| PJP | 125.45 | 0.60 | +0.48% |
| Invesco Pharmaceuticals ETF | |||
| CPRY | 28.16 | -0.01 | -0.05% |
| Calamos Russell 2000 Str Alt Prt ETF-Jan | |||
| IBDV | 21.58 | -0.06 | -0.25% |
| iShares iBonds Dec 2030 Term Corp ETF | |||
| IZRL | 29.77 | -0.19 | -0.63% |
| ARK Israel Innovative Technology ETF | |||
A.I.dvisor indicates that over the last year, CLSDX has been closely correlated with VMGIX. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLSDX jumps, then VMGIX could also see price increases.
| Ticker / NAME | Correlation To CLSDX | 1D Price Change % | ||
|---|---|---|---|---|
| CLSDX | 100% | N/A | ||
| VMGIX - CLSDX | 81% Closely correlated | N/A | ||
| VMGMX - CLSDX | 81% Closely correlated | N/A | ||
| PMAQX - CLSDX | 40% Loosely correlated | N/A | ||
| PMBPX - CLSDX | 40% Loosely correlated | N/A | ||
| PMBMX - CLSDX | 39% Loosely correlated | N/A |